Novel agents in the treatment of intestinal failure: humoral factors.
about
Intestinal epithelial cell-derived interleukin-7: A mechanism for the alteration of intraepithelial lymphocytes in a mouse model of total parenteral nutrition.Specific overexpression of IL-7 in the intestinal mucosa: the role in intestinal intraepithelial lymphocyte development.Modulation of mouse intestinal epithelial cell turnover in the absence of angiotensin converting enzyme.Early but not late administration of glucagon-like peptide-2 following ileo-cecal resection augments putative intestinal stem cell expansion.Intestinal specific overexpression of interleukin-7 attenuates the alternation of intestinal intraepithelial lymphocytes after total parenteral nutrition administration.
P2860
Novel agents in the treatment of intestinal failure: humoral factors.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Novel agents in the treatment of intestinal failure: humoral factors.
@en
Novel agents in the treatment of intestinal failure: humoral factors.
@nl
type
label
Novel agents in the treatment of intestinal failure: humoral factors.
@en
Novel agents in the treatment of intestinal failure: humoral factors.
@nl
prefLabel
Novel agents in the treatment of intestinal failure: humoral factors.
@en
Novel agents in the treatment of intestinal failure: humoral factors.
@nl
P2860
P1433
P1476
Novel agents in the treatment of intestinal failure: humoral factors.
@en
P2093
Daniel H Teitelbaum
P2860
P304
P356
10.1053/J.GASTRO.2005.08.059
P407
P433
P577
2006-02-01T00:00:00Z